Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to Be Interviewed Live Today on Clear Channel Bus. Talk Radi...
February 25 2014 - 11:03AM
Marketwired
Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to
Be Interviewed Live Today on Clear Channel Business Talk Radio
DFW1190AM
Interview at 1:05 pm CST / 2:05 pm EST on The Traders Network
Radio Show, Hosted by Michael Yorba
DALLAS, TX and IRVINGTON, NY--(Marketwired - Feb 25, 2014) -
MELA Sciences, Inc. (NASDAQ: MELA), developer of MelaFind®, an FDA
approved optical diagnostic device that assists dermatologists in
melanoma diagnosis, announced that its CEO Rose Crane will be
interviewed live today by host Michael Yorba on Clear Channel
Business Talk Radio's The Traders Network. All
interested investors and prospective customers across the US are
encouraged to tune in and listen live via Clear Channel's
nationally syndicated iHeart Radio stream.
The live interview details are as follows:
Date: Today, Tuesday, February 25, 2014 Start Time: 1:05pm CST |
11:05 am PST | 2:05 pm EST (U.S.) Network: Clear Channel
Station: DFW 1190AM Dallas-Ft. Worth Host: Michael
Yorba Live Radio Stream:
http://www.iheart.com/live/4276/?autoplay=true
About Clear Channel: Clear Channel's Media and Entertainment
division has the largest reach of any radio or television outlet in
America with 243 million monthly listeners. It serves 150 cities
through 850 owned radio stations in the U.S., as well as more than
140 stations in New Zealand and Australia.
www.clearchannel.com.
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and
featured host on Clear Channel. For the past six years he has been
integrally involved with producing and hosting a daily talk show
called Commodity Classics, and The Traders Network.
From the fast action of the trading pit... to the power brokers
making the headlines... Michael Yorba interviews the front-page
Titans about the latest in capital markets, CEO milestones, trading
tools, real estate acquisitions and market trends. Learn how the
experts use risk management techniques to build fully diversified
portfolios and what it takes to put up big board earnings. It's a
fast moving, high-energy show that presents stocks, commodities,
bonds, forex, derivatives, real estate, political trends,
technology trends, crowd funding and impact investment insights in
a new light and keeps investors and consumers asking for more...
The Traders Network stays ahead of the curve by featuring leading
market and business professionals, sophisticated technology, and
the analytics needed to identify the most lucrative investment
strategies. Successful performance depends on finding the right
opportunities. So... shift your thinking and join us as we deliver
"tomorrow's ideas today" on Clear Channel's The Traders Network
Monday - Friday from 1:00pm - 3:00pm CST live after Glenn Beck.
About MELA Sciences, Inc. (www.melasciences.com) MELA Sciences
is a medical device company developing dermatology diagnostics
utilizing state-of-the-art optical imaging. The flagship product is
MelaFind®, an FDA, PMA and CE Mark approved, non-invasive
diagnostic tool to aid dermatologists in melanoma evaluation and
diagnosis. MelaFind® uses a variety of visible to near-infrared
light waves to evaluate skin lesions from the surface to 2.5 mm
beneath the skin. It provides images and data on the relative
disorganization of a lesion's cell structure that provides
substantial additional perspective to aid melanoma diagnosis. MELA
is also exploring new potential uses for its core imaging
technology and algorithms.
Twitter: MELASciencesIR or MelaFind Facebook: MelaFind
StockTwits: MELASciencesIR BoardVote: MELA Sciences
A www.1800PublicRelations.com PR
Event
Contact: Media MELA Sciences, Inc. Diana Garcia Redruello
212-518-4226 dgarcia@melasciences.com or Investors Catalyst Global
Toni Trigiani, David Collins 212-924-9800 mela@catalyst-ir.com
Press/Media Contact: Matthew Bird MUNCmedia Public Relations +1
(917) 409-8211 matt.bird@muncmedia.com www.muncmedia.com
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Mar 2023 to Mar 2024